isothiocyanic acid has been researched along with Malignant Melanoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Calviello, G; Celleno, L; Guarino, R; Ottes Vasconcelos, R; Serini, S | 1 |
| Anestopoulos, I; Atkinson, A; Botaitis, S; Franco, R; Mantso, T; Mitsiogianni, M; Panayiotidis, MI; Pappa, A; Perente, S; Sfakianos, AP; Simopoulos, C; Vasileiadis, S | 1 |
| Amin, S; Crampsie, MA; Prakasha Gowda, AS; Sharma, AK; Sk, UH; Spratt, TE; Yun, JK | 1 |
3 other study(ies) available for isothiocyanic acid and Malignant Melanoma
| Article | Year |
|---|---|
The Combination of Sulforaphane and Fernblock
Topics: Antineoplastic Agents; Antioxidants; Brassica; Cell Line, Tumor; Cell Movement; Humans; Inflammasomes; Interleukin-1beta; Isothiocyanates; Keratinocytes; Matrix Metalloproteinases; Melanoma; NLR Family, Pyrin Domain-Containing 3 Protein; Plant Extracts; Skin; Skin Aging; Sulfoxides | 2020 |
Development of a Novel Experimental In Vitro Model of Isothiocyanate-induced Apoptosis in Human Malignant Melanoma Cells.
Topics: Apoptosis; Cell Line, Tumor; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Isothiocyanates; Melanoma | 2016 |
Development of novel naphthalimide derivatives and their evaluation as potential melanoma therapeutics.
Topics: Animals; Annexin A5; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Flow Cytometry; Humans; Hydrophobic and Hydrophilic Interactions; Injections, Intraperitoneal; Isothiocyanates; Melanoma; Mice; Mice, Nude; Naphthalimides; Neoplasm Transplantation; Skin Neoplasms; Structure-Activity Relationship; Thiourea | 2011 |